Compass Therapeutics Ratios (2023-2025) | CMPX

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -1,538.35%
EBIT Margin -1,770.00%
EBITDA Margin -1,538.47%
Operating Margin -1,770.00%
Net Margin -1,538.35%
FCF Margin -1,265.18%
Efficiency
Assets Average 183.58M174.61M163.46M159.01M158.38M152.38M144.78M135.93M124.07M173.98M
Equity Average 171.78M164.17M154.29M152.80M151.58M142.25M131.82M117.76M101.74M151.41M
Invested Capital 175.26M168.29M160.04M148.54M157.06M146.10M138.40M125.23M110.28M93.21M209.61M
Asset Utilization Ratio 0.010.010.010.01
Leverage & Solvency
Equity Ratio 0.930.940.940.950.970.940.930.890.840.800.91
Valuation
Enterprise Value -175.17M-168.75M-163.70M-152.46M-176.06M-146.23M-135.97M-127.29M-113.20M-101.52M-220.46M
Return Ratios
Return on Sales -15.38%-58.26%-61.97%-68.85%
Return on Capital Employed -0.32%-0.34%-0.37%-0.37%-0.42%-0.51%-0.62%-0.44%
Return on Assets -0.26%-0.29%-0.30%-0.32%-0.36%-0.43%-0.54%-0.40%
Return on Equity -0.28%-0.30%-0.31%-0.35%-0.40%-0.50%-0.65%-0.46%